首页>
外文期刊>Disease Prevention Daily.
>Reports from University of Pittsburgh Advance Knowledge in Biomarkers (Neutrophil Extracellular Traps As a Novel Biomarker To Predict Recurrence-free and Overall Survival In Patients With Primary Hepatic Malignancies)
【24h】
Reports from University of Pittsburgh Advance Knowledge in Biomarkers (Neutrophil Extracellular Traps As a Novel Biomarker To Predict Recurrence-free and Overall Survival In Patients With Primary Hepatic Malignancies)
2021 MAY 03 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Fresh data on Diagnostics and Screening - Biomarkers are presented in a new report. According to news reporting out of Pittsburgh, Pennsylvania, by NewsRx editors, research stated, "The incidence of primary hepatic malignancies including Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) is on the rise, (i) Surgery remains the mainstay of potential curative treatment, however the vast majority of patients will recur and not be amenable to curative therapy, (ii) Inflammation has been associated with poor prognosis, however there is no preoperative marker that can predict recurrence -free-or overall survival. Our aim is to correlate inflammation measured as neutrophil extracellular traps (NETs) with survival." Financial support for this research came from Burroughs Wellcome Fund.
展开▼
